Leukocyte immunoglobulin-like receptor B2 overexpression as a promising therapeutic target and noninvasive screening biomarker for colorectal cancer

Figure 2 Correlation of leukocyte immunoglobulin-like receptor B2 and angiopoietin-like protein 2 expression at the mRNA and protein levels in colorectal cancer. A: Correlation at the mRNA level in colorectal cancer (CRC); B: Correlation at the protein level in CRC; C: Immunohistochemical staining of leukocyte immunoglobulin-like receptor B2 (LILRB2) in paracancerous tissue; D: Low expression of LILRB2 in CRC tissue; E: High expression of LILRB2 in CRC tissue; F: Immunohistochemical staining of angiopoietin-like protein 2 (ANGPTL2) in paracancerous tissue; G: Low expression of ANGPTL2 in CRC; H: Overexpression of ANGPTL2 in CRC. LILRB2: Leukocyte immunoglobulin-like receptor B2; ANGPTL2: Angiopoietin-like protein 2; CRC: Colorectal cancer.